Skip to main content

Peer Review reports

From: CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy

Original Submission
14 Sep 2017 Submitted Original manuscript
10 Oct 2017 Author responded Author comments - Jin Ye
Resubmission - Version 2
10 Oct 2017 Submitted Manuscript version 2
11 Nov 2017 Reviewed Reviewer Report - D. Callinice Capo-Chichi
30 Dec 2017 Reviewed Reviewer Report - Josip Blonder
3 Jan 2018 Author responded Author comments - Jin Ye
Resubmission - Version 3
3 Jan 2018 Submitted Manuscript version 3
23 Mar 2018 Reviewed Reviewer Report - Olle Stal
4 May 2018 Author responded Author comments - Bray Denard
Resubmission - Version 4
4 May 2018 Submitted Manuscript version 4
25 Jun 2018 Reviewed Reviewer Report - Olle Stal
11 Jul 2018 Author responded Author comments - Bray Denard
Resubmission - Version 5
11 Jul 2018 Submitted Manuscript version 5
Publishing
3 Aug 2018 Editorially accepted
13 Aug 2018 Article published 10.1186/s12885-018-4724-8

You can find further information about peer review here.

Back to article page